GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Change In Receivables

Fabino Life Sciences (BOM:543444) Change In Receivables : ₹-101.9 Mil (TTM As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Fabino Life Sciences Change In Receivables?

Fabino Life Sciences's change in receivables for the quarter that ended in Mar. 2024 was ₹-82.9 Mil. It means Fabino Life Sciences's Accounts Receivable increased by ₹82.9 Mil from Sep. 2023 to Mar. 2024 .

Fabino Life Sciences's change in receivables for the fiscal year that ended in Mar. 2024 was ₹-101.9 Mil. It means Fabino Life Sciences's Accounts Receivable increased by ₹101.9 Mil from Mar. 2023 to Mar. 2024 .

Fabino Life Sciences's Accounts Receivable for the quarter that ended in Mar. 2024 was ₹126.1 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Fabino Life Sciences's Days Sales Outstanding for the six months ended in Mar. 2024 was 279.95.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Fabino Life Sciences's liquidation value for the six months ended in Mar. 2024 was ₹-10.2 Mil.

Fabino Life Sciences Change In Receivables Historical Data

The historical data trend for Fabino Life Sciences's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fabino Life Sciences Change In Receivables Chart

Fabino Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Change In Receivables
Get a 7-Day Free Trial 3.84 9.65 -5.75 -12.83 -101.85

Fabino Life Sciences Semi-Annual Data
Mar19 Mar20 Mar21 Mar22 Sep22 Mar23 Sep23 Mar24
Change In Receivables Get a 7-Day Free Trial - 0.96 -13.80 -18.97 -82.89

Fabino Life Sciences Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-101.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Life Sciences  (BOM:543444) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Fabino Life Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=126.119/82.216*91
=279.95

2. In Ben Graham's calculation of liquidation value, Fabino Life Sciences's accounts receivable are only considered to be worth 75% of book value:

Fabino Life Sciences's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.62-112.126+0.75 * 126.119+0.5 * 13.346
=-10.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fabino Life Sciences Change In Receivables Related Terms

Thank you for viewing the detailed overview of Fabino Life Sciences's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Fabino Life Sciences (BOM:543444) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fabino Life Sciences Ltd (BOM:543444) » Definitions » Change In Receivables
Comparable Companies
BOM:531541 BOM:524661 BOM:531686 BOM:524516 BOM:530207 BOM:539680 BOM:531762 BOM:540108 BOM:524322 BOM:524590 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Murthal Road,, Shubham Garden, Jeevan Vihar Extension Near, Sonipat, HR, IND, 131001
Website
https://www.fabinolife.com
Fabino Life Sciences Ltd is a pharmaceutical company. It is engaged in manufacturing, marketing, trading and packing of pharmaceutical and other wellness-focused consumer products. It offers a wide range of allopathic, Food and wellness, Veterinary, Multi-vitamin and herbal products. The company currently supplies in Haryana, Delhi, parts of Punjab, Himachal Pradesh, Eastern Uttar Pradesh, Orissa, and Jharkhand, and parts of West Bengal, Andhra Pradesh, and Nepal.

Fabino Life Sciences (BOM:543444) Headlines

No Headlines